The stress-inducible small heat shock protein (shsp)/aB-crystallin gene is expressed highly in the lens and moderately in other tissues. Here we provide evidence that it is a target gene of the aryl hydrocarbon receptor (AhR) transcription factor. A sequence (2329/2323, CATGCGA) similar to the consensus xenobiotic responsive element (XRE), called here XRE-like, is present in the aBE2 region of aB-crystallin enhancer and can bind AhR in vitro and in vivo. aB-crystallin protein levels were reduced in retina, lens, cornea, heart, skeletal muscle and cultured muscle fibroblasts of AhR 2/2 mice; aB-crystallin mRNA levels were reduced in the eye, heart and skeletal muscle of AhR 2/2 mice. Increased AhR stimulated aB-crystallin expression in transfection experiments conducted in conjunction with the aryl hydrocarbon receptor nuclear translocator (ARNT) and decreased AhR reduced aB-crystallin expression. AhR effect on aB-crystallin promoter activity was cell-dependent in transfection experiments. AhR up-regulated aB-crystallin promoter activity in transfected HeLa, NIH3T3 and COS-7 cells in the absence of exogenously added ligand (TCDD), but had no effect on the aB-crystallin promoter in C 2 C 12 , CV-1 or Hepa-1 cells with or without TCDD. TCDD enhanced AhR-stimulated aB-crystallin promoter activity in transfected aTN4 cells. AhR could bind to an XRE-like site in the aB-crystallin enhancer in vitro and in vivo. Finally, site-specific mutagenesis experiments showed that the XRE-like motif was necessary for both basal and maximal AhR-induction of aB-crystallin promoter activity. Our data strongly suggest that AhR is a regulator of aB-crystallin gene expression and provide new avenues of research for the mechanism of tissue-specific aB-crystallin gene regulation under normal and physiologically stressed conditions.
Introduction
The aB-crystallin and HspB2 genes, both members of the small heat shock protein gene family, are arranged head-to-head with an approximate 1 kb intergenic region in the human, mouse and rat genomes [1] . In the mouse, the intergenic sequence contains an orientation-dependent enhancer that differentially directs expression of the aB-crystallin gene to different tissues, with the highest expressions being in the eye lens, heart and skeletal muscle [2, 3] . Although little is known about regulation of HspB2 gene expression, aB-crystallin gene expression has been well studied. Specific transcription factors are known that regulate the proximal promoter and each of the enhancer cis-elements, except for the aBE2 enhancer element, of the aB-crystallin gene [4, 5, 6, 7, 8, 9] (Fig. 1) .
In the present investigation we scanned the HspB2/aB-crystallin intergenic regulatory region and identified a candidate aryl hydrocarbon receptor(AhR) binding site, CATGCGA, at the edge of aBE2 (Fig. 1) . The DNA binding site for AhR is called the xenobiotic responsive element (XRE) or dioxin response element (DRE) [10, 11] . The core consensus sequence for a functional XRE present in enhancers of known AhR-regulated genes (i.e. cyp1a1, cyp1a2, cyp1b1) is CACGCNA. Recently another AhR recognizing sequence, XRE-II, was recognized in the enhancer of cyp1a2 [12] ; XRE-II binds the AhR/aryl hydrocarbon receptor nuclear translocator (ARNT) with the mediation of an unknown protein.
The core sequence of XRE-II is identified as CATG{N 6 }C[T/ A]TG [12, 13] . Since the potential AhR binding site in the aBE2 of aB-crystallin is not a perfect match with either XRE-I or XRE-II, we term this site the XRE-like motif.
AhR belongs to the bHLH /PAS (basic Helix-Loop-Helix/Per Arnt Sim) transcription factor family. Members of this family play critical roles in a broad range of biological functions including regulation of circadian rhythm, neurogenesis, hypoxia response and drug metabolism. A well-established mechanism for AhR function of detoxification starts from its activation by a ligand, usually a dioxin, followed by transport to the cell nucleus, where the AhR forms a heterodimer with ARNT. The AhR/ARNT complex binds to XRE motifs in the regulatory regions of its target genes. Most AhR-regulated genes (cyp1a1, cyp 1a2, cyp 1b1, glutathione-S-transferase Ya and NAD(P)H-quinone oxidoreductase) metabolize xenobiotics [14, 15, 16] . While the detoxification role of AhR has been well investigated, very little is known about the other functions of this ancient protein. Recent studies on AhR null mice have revealed de novo physiologic functions of AhR in addition to induction of detoxification genes, and many new potential AhR regulated genes have been identified by highthroughput technologies [13, 17, 18] . The present study provides evidence that AhR regulates small heat shock protein/aB-crystallin gene expression in a ligand-independent fashion.
Results

aB-Crystallin is Decreased in AhR Null Mice
We examined aB-crystallin expression levels in different tissues of adult AhR 2/2 and AhR +/+ mice [19] . aB-crystallin protein levels in the retina, lens, cornea, heart and skeletal muscles were reduced in AhR 2/2 mice compared to AhR +/+ mice ( Fig. 2A ). The retina, lens, cornea, heart and skeletal muscle contain either abundant (lens, heart, skeletal muscle) or moderate (cornea, retina) levels of aB-crystallin [20, 21, 22, 23] . aB-crystallin was undetectable in the retina and reduced by approximately 3-fold in the cornea, heart and skeletal muscle, and 2-fold in the lens of AhR 2/2 mice. b-actin was at comparable levels in these tissues in the AhR 2/2 and AhR +/+ mice. aB-crystallin mRNA levels were reduced approximately 7-fold in the eyes (whole eyeball), 3-fold in the heart and 2-fold in skeletal muscle of the AhR 2/2 mice compared to the age-matched AhR +/+ mice (Fig. 2B) .
We also compared the levels of aB-crystallin in primary cultures of muscle derived fibroblast cells from AhR 2/2 and AhR +/+ mice ( Fig. 2A) . There was much less ( 0.3-fold) aB-crystallin in AhR 2/2 fibroblasts compared to AhR +/+ fibroblasts. The absence of AhR in the primary AhR 2/2 fibroblast cells was confirmed by immunoblotting (data not shown).
We next tested whether reducing AhR levels by siRNA or increasing AhR levels using plasmids encoding AhR and ARNT would affect aB-crystallin levels in cultured rabbit lens aTN4 cells. AhR siRNA reduced AhR level by 65% and aB-crystallin level by 78%, respectively (Fig. 3A) . By contrast, overexpression of AhR/ARNT increased aB-crystallin expression in a dose dependent manner (Fig. 3B) . Together, these results are consistent with AhR being a positive regulator of aB-crystallin gene expression.
AhR/ARNT Upregulates aB-crystallin Promoter Activity Independently of Exogenous Ligand
We next examined whether AhR can regulate aB-crystallin promoter activity. We used a duel reporter plasmid, pFLHspB2aBRL [3] , which contains the 1 kb intergenic regulatory region between the head-to-head aB-crystallin and HspB2 genes. In this plasmid the proximal promoter of HspB2 drives the firefly luciferase gene and the proximal promoter of aB-crystallin drives the Renilla luciferase gene (Fig. 4A) , thus allowing us to detect the effect of transcription factors on each of the promoters simultaneously. HeLa cells were transfected with the plasmids encoding mouse AhR and ARNT and the Renilla and firefly luciferase activities were determined. As shown in Fig. 4B , AhR/ARNT had no significant effect on HspB2 promoter activity, but increased aB-crystallin promoter activity by 9.1-fold. In order to identify individual contributions of AhR and ARNT, we tested their dose effects individually on aBcrystallin promoter activity. AhR and ARNT each up-regulated aB-crystallin promoter activity in a dose-dependent fashion; the combination of AhR and ARNT had an additive positive effect on the activity of the aB-crystallin promoter (Fig. 5A) . By contrast, AhR/ARNT had little, if any, effect on HspB2 promoter activity (data not shown).
Unexpectedly, our data indicated that AhR does not require an exogenous ligand to stimulate aB-crystallin promoter activity. Thus, we further tested the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the prototypical ligand of AhR [15, 16, 24] , on the ability of AhR to stimulate aB-crystallin promoter activity. Fig. 5B shows that TCDD did not augment the stimulation of aB-crystallin promoter activity by AhR/ARNT. In additional tests, a high ligand-affinity AhR (C57BL/6AhR) and a low ligand-affinity AhR (DBA/2AhR) [25] up-regulated aB-crystallin promoter activity by 7.8-fold and 9.2-fold, respectively, in the absence of TCDD ( Fig. 5C ), confirming the ligand-independence of AhR stimulation of aB-crystallin promoter activity.
It has been reported that AhR activity differs among cell types [24, 25, 26] . Thus we examined the AhR/ARNT regulation on aBcrystallin promoter in seven different cell lines and used the cyp1a1 promoter, a target gene positively regulated by AhR/ARNT [10, 11] , as a positive control. Interestingly, the results differed with cell type (Fig. 6 ). In HeLa, NIH3T3 and COS-7 cells, AhR/ARNT increased aB-crystallin promoter activity by 11.3-fold, 5.5-fold and 3.3-fold, respectively, in a TCDD-independent manner; in CV-1, C 2 C 12 and Hepa-1 cells, AhR/ARNT did not stimulate aB-crystallin promoter activity; in aTN4 lens cells, AhR/ARNT increased aBcrystallin promoter activity by 2.1-fold, and this stimulation was increased to 4.2-fold by the addition of TCDD. As expected, AhR/ ARNT increased cyp1a1 promoter activity in all the cell types tested; AhR/ARNT stimulation was appreciably increased by the addition of TCDD in HeLa, COS-7 and Hepa-1 cells, moderately enhanced in C 2 C 12 cells, and slightly elevated if at all in NIH3T3 and CV-1 cells (Fig. 6) . We conclude from these experiments that AhR/ ARNT can positively regulate aB-crystallin promoter activity TCDD independently or dependently depending upon the cell type.
AhR Binds the XRE-like Motif in the aB-Crystallin
59-Regulatory Region
Gel shift and ChIP assays were performed to test whether AhR can bind the XRE-like motif that we identified in the aB-crystallin enhancer. In gel shift experiments using aTN4 cell nuclear extracts and a 22 bp oligonucleotide containing the XRE-like motif (indicated in Fig. 7C as aB-wt), a weak but specific band representing the AhR/XRE-like motif complex was detected in untreated aTN4 cells (Fig. 7B, lane 2) . AhR/ARNT transfection and TCDD addition increased the band intensity individually ( (Fig. 7B, lane 9) . In further gel shift experiment using HeLa cells (data not shown), the specific band of complex was more intense using nuclear extracts from cells transfected with the AhR/ARNT vector than from cells transfected with the control vector (pcDNA3.1). Not as in the experiments with the aTN4 cells, TCDD did not increase the band intensity in the experiments with HeLa cells. These results are consistent with our functional tests using aTN4 and HeLa cells indicating that AhR regulates the aB-crystallin promoter (see Fig. 6 ).
We next examined the binding specificity of AhR to the XRElike motif (CATGCGA) by mutating this site (aB-wt) to an XRE-I (CACGCAA) sequence (aB-mu1+), an XRE-II (CATGCC-CAATCTT) sequence (aB-mu2+), or a sequence lacking an Figure 2 . aB-crystallin is decreased in AhR 2/2 mice. A. Cornea, retina, lens, heart, and skeletal muscle were isolated from adult AhR 2/2 and AhR +/+ mice and tissue proteins extracted. Primary fibroblasts from skeletal muscle were cultured and cell proteins extracted. aB-crystallin was analyzed by Western immunoblotting. b-actin was detected as an internal control. (n = 4, *, p,0.05). B. aB-crystallin mRNA levels were determined by real time-PCR using total RNA extracted from whole eyes, heart and limb skeletal muscle. GAPDH mRNA levels were determined as an internal control (n = 2, **, p,0.01). doi:10.1371/journal.pone.0017904.g002
XRE site (aB-mu2; CAAAAAA) (Fig. 7C ). Protein-oligonucleotide complex formation was more intense with the aB-mu1+ sequence (Fig. 7C , lane 2) and weaker with the aB-mu2+ sequence (lane 3) than with the aB-wt sequence (Fig. 7C , lane 1). No discrete band was produced with the aB-mu2 (Fig. 7C, lane 4) . These results are consistent with DNA sequence-specific binding of AhR to XRE-related motifs.
A previous report indicated that in vitro translated AhR/ARNT does not bind to the XRE-II motif, suggesting that in vivo binding requires additional proteins or posttranslational modification(s) [12] . Therefore, we examined the capacity of in vitro translated AhR/ARNT to bind the XRE-like motif (Fig. 7D) . The AhR/ ARNT generated by a rabbit reticulocyte expression system bound the XRE-I motif in the presence of TCDD (100 nM) (Fig. 7D , lane 2) but did not bind the XRE-like motif in the gel shift experiments (Fig. 7D, lane 3,4) . Either binding of the in vitro generated AhR/ARNT to the XRE-like and/or XRE-II sequences required modification that was not performed by the system, or other factor(s) are needed for binding to occur.
The binding abilities of AhR to the XRE-like, XRE-I and XRE-II motifs were compared by competition experiments using HeLa cells (Fig. 8) . A 10, 25, and 100-fold molar excess of XRE-I motif gradually eliminated the binding of AhR to the XRE-like motif (Fig. 8, Lane 1-4) ; by contrast, appreciable complex of AhR to the XRE-I sequence remained even at a 100-fold molar excess of the XRE-like sequence (Fig. 8, lanes 5-8) , consistent with stronger AhR binding to XRE-I than to the XRE-like sequence. There was no competition for AhR binding between the XRE-like and the XRE-II motifs (Fig. 8, lanes 9-16) .
We next tested the in vivo interaction of AhR with the XRE-like motif in aTN4 cells by ChIP analysis (Fig. 9) . DNA isolated from anti-AhR antibody precipitated complexes was amplified by PCR and real time-PCR using a pair of primers that could amplify the sequence containing the XRE-like motif (Fig. 9A) . The predicted band of 250 bp was detected in untransfected aTN4 cells indicating complex formation in the untreated cells. In AhR/ ARNT transfected aTN4 cells, a much stronger band was detected and TCDD addition further increased the band intensity (Fig. 9B, C) . The results of these ChIP experiments are consistent with our functional transfection and gel mobility shift experiments suggesting an in vivo role for AhR in aB-crystallin gene expression.
The XRE-like Motif is Necessary for Basal aB-Crystallin Promoter Activity and Maximal AhR/ARNT-Inducible aBCrystallin Promoter Activity
We tested the functional importance of the XRE-like motif for aB-crystallin promoter activity. The XRE-like motif in the reporter construct was mutated either to an XRE-I sequence or to a non-XRE sequence identical to those used for the binding assays above (Fig. 10) . Mutating the XRE-like motif to a non-XRE sequence reduced basal promoter activity by 85% and reduced maximal AhR/ARNT-induced promoter activity by 86% relative to the wild type aB-crystallin promoter activity (Fig. 10) . Thus the XRElike motif is necessary and important for basal aB-crystallin promoter activity and maximal AhR/ARNT-inducibility.
Discussion
The present report suggests that aB-crystallin is a target gene for the transcription factor, AhR. aB-crystallin protein expression was reduced in the eyes (lens and cornea), heart, skeletal muscle and primarily cultured fibroblasts in AhR 2/2 mice. The AhR 2/2 mice had no detectable aB-crystallin in the retina, where both aBcrystallin and AhR are known to be prevalent in vertebrates and invertebrates [22, 23, 27, 28, 29, 30] . Although no connection is known between aB-crystallin and retinal function, it is noteworthy that disruption of the Drosophila AhR ortholog, Spineless, disables color vision in this species [29] . The present data indicate that aB-crystallin protein and mRNA levels are decreased in the eyes of AhR 2/2 mice; however, histological examination of these eyes revealed no obvious morphological abnormality in the eyes of either adult or 19 dayold postnatal pups of AhR 2/2 mice (data not shown). In this connection, it is noteworthy and consistent with reports that although AhR protein [31, 32] and aB-crystallin mRNA [33] are highly expressed in the lens of 12-15 day-old mouse embryos, the lenses of neither AhR null mice [34] nor aB-crystallin [35] null mice appear abnormal. Thus, the precise developmental roles of AhR and aB-crystallin in the lens, as well as in other tissues, require additional investigation.
Our strongest evidence that AhR regulates aB-crystallin gene expression comes from the combination of transfection experiments that tested for promoter function and gel mobility shift assays that tested for direct binding to DNA. AhR stimulated the aB-crystallin promoter in transfected cells and formed a complex with the XRE-like site in the aB-crystallin enhancer. Mutation of this site reduced both promoter activation and AhR binding. Mutation of the XRE-like site also lowered the basal promoter activity of the aB-crystallin gene as well as the ability of the promoter to be activated by AhR. It is noteworthy, however, that AhR did not stimulate aB-crystallin promoter activity in all types of transfected cells. Positive results were obtained in HeLa, NIH3T3, COS-7 and aTN4 cells, but not in C 2 C 12 , CV-1 or Hepa-1 cells. The reason for this cell type-dependency is not known, but suggests that specific interaction with one or more factors is essential. It is also intriguing that although the XRE-like site is necessary for both basal promoter activity and AhR-stimulation of promoter activity, it binds AhR weakly. One possibility for the weak binding in our tests is that additional proteins that were not present in the gel shift reaction mixture are required for maximal complex formation. The inability of in vitro translated AhR/ARNT to form a complex with the XRE-like site is consistent with this possibility. Further studies on AhR binding to the aB-crystallin promoter both in vivo and in vitro using physiological levels of nuclear proteins are warranted.
Our in vitro functional and gel shift experiments, as well as ChIP experiments, indicate that AhR can stimulate aB-crystallin promoter activity in the absence of TCDD. A caveat is that TCDD increase of AhR stimulation of the aB-crystallin promoter depends on cell type (i.e. aTN4 cells). AhR can also regulate other gene expression, for example TGFb1, independently of TCDD [36] . Indeed, the expression of a large number of genes not affected by TCDD in different tissues was altered in AhR 2/2 mice [17, 18] . It is unknown whether these represent direct or indirect effects of AhR. The genes altered in the AhR null mice are enriched for classic XRE sites, and it is likely that various transcription factors collaborate with AhR in a combinatorial fashion to regulate tissue-specific mRNA regulation in wild type mice [18] . It remains possible, of course, that a yet unknown endogenous ligand substitutes for TCDD in certain cases or under specific conditions. FICZ (6-formylindolo[3,2-b]carbazole) and/or other tryptophan derivatives are candidate endogenous ligands for AhR [37] .
Finally it is noteworthy that in preliminary tests (data not shown) AhR/ARNT increased the activity of a truncated aB-crystallin promoter lacking the XRE-like site (2257 to +43) up to 24% of the AhR/ARNT-induced wild type promoter. Since the identified XRE-like site is the only sequence resembling a classical XRE sequence in the 59 flanking region of the aB-crystallin gene, it is possible that AhR stimulated aB-crystallin activity of the truncated promoter by binding another sequence via one or more scaffolding proteins. Alternatively, AhR/ARNT may have activated another gene that in turn stimulated activity of the truncated promoter. Further studies are necessary to resolve the multiple interactions involved in aB-crystallin gene expression.
In summary, whatever the mechanism, our data suggest that AhR/ARNT participates in the regulation of the aB-crystallin gene. Apart from its intrinsic interest with respect to the complex mechanism of aB-crystallin gene expresssion [38, 39] , AhR regulation of the aB-crystallin gene is biologically logical: both aB-crystallin and AhR function in mediating cellular stress responses [39, 40] .
Materials and Methods
Chemicals and Antibodies
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased from Cambridge Isotope Laboratories, Inc. Anti-AhR antibody (RPT9) and anti-ARNT antibody (2B10) were purchased from Abcam Inc. Anti-aB-crystallin antibody was purchased from Stressgen. Anti-b-actin antibody was purchased from Sigma. AntiHistone H3 antibody was purchased from Abcam Inc.
Cell Lines-HeLa (CCL-2) cells, Hepa1-6 (CRL-1830) cells, C 2 C 12 (CRL-1772) cells, NIH3T3(CRL-1658) cells, CV-1 (CCL-70) and COS-7 (CRL-1651) cells were purchased from ATCC and maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum. aTN4 cells were maintained as previously described [8] .
Plasmids and Site-Directed Mutagenesis
The plasmids encoding mouse AhR protein (pcDNA3.1/ B6AhR and pcDNA3.1/D2AHR) and the cyp1a1 reporter plasmid (P1646luc3) were kindly provided by Dr. Alvaro Puga (University of Cincinnati College of Medicine). The plasmid encoding mouse ARNT protein (pcDNA/ARNT) was kindly provided by Dr. Oliver Hankinson (University of California, Los Angeles, California). The dual-directional reporter plasmid pFLHspB2aBRL (in which RL is Renilla luciferase and FL is firefly luciferase) is described elsewhere [3] . Site-directed mutagenesis was performed with the QuikChange Site-Directed Mutagenesis kit (Stratagene). The primers containing mutated site were synthesized by Integrated DNA Technologies Inc as follows: aB-mu1+: 59-TCA ATT CCC CTG GCA CGC AAG ACT GGA GAG (in which CATGCGARCACGCAA); aB-mu1-: 59-GGC TCA ATT CCC CTG GCA AAA AA G ACT GGA GAG GAG GAG GGG (in which CATGCGARCAAAAAA).
siRNA Experiments-Small interfering RNA (siRNA) targeting mouse AhR (si-AhR) and non-targeting siRNA (si-ctrl) were synthesized by Dharmacon. 80 pmol of si-AhR and si-ctrl were transfected into aTN4 cells using Lipofectamine2000 (Invitrogen). Total cell protein was extracted by RIPA buffer (Pierce) after 60 h and AhR, aB-crystallin and b-actin protein levels were estimated by immunoblotting.
Transfection and Reporter Gene/Luciferase Assay
Cells were grown in 24-well plates to 40-50% confluence and co-transfected with pcDNA3.1/B6AhR, pcDNA/ARNT or pcDNA3.1 (vector) and reporter plasmids using Fugene6 (Roche Applied Science). pCMVb-gal (Clontech) or pRL-CMV (Promega) was co-transfected to normalize for transfection efficiency. TCDD (10 nM) or DMSO (0.01%) was added into the culture medium 24 h after transfection and the cells were incubated for another 24 h. Luciferase activities were determined in 20 ml of cell lysate by a Dual Luciferase Assay kit (Promega) on a GloMax TM 96 microplate luminometer (Promega). Relative luciferase activities (Relative Luciferase Unit, RLU) were expressed as the ratio of the promoter activities generated by the reporter plasmid to that of the control plasmid. Fold change was recorded as the ratio of RLU from experimental group versus control group. Figure 6 . AhR/ARNT up-regulates aB-crystallin promoter activity in a cell-type dependent manner. pFLHspB2aBRL or the cyp1a1 reporter plasmid was co-transfected with pcDNA3.1/B6AhR, pcDNA/ARNT and b-gal control vector into the specified cells as indicated and the cells were cultured for 24 h. Cells were incubated with TCDD (10 nM) or DMSO (0.01%) for another 24 h before luciferase activities were determined. The fold change was recorded by determining luciferase activity in AhR/ARNT transfected and/or TCDD-treated cells relative to that in the pcDNA3.1 transfected and DMSO-treated cells. The means and S.D. values were derived from three independent experiments. Three types of AhR/ARNT and TCDD induced-aB-crystallin promoter responses were detected, depending on the cell type, as indicated under the boxed results. AhR/ARNT increased Cyp1a1 promoter activity in all the cell types tested and showed variable, cell-type dependent additional stimulation in the presence of TCDD. doi:10.1371/journal.pone.0017904.g006 Figure 7 . AhR binds to the XRE-like motif in the aB-crystallin enhancer. A. Nuclear AhR levels in aTN4 cells. aTN4 cells were transfected with pcDNA3.1/B6AhR and pcDNA/ARNT or pcDNA3.1 for 24 h, treated with or without 10 nM TCDD for 2 h, and then nuclear extracts were prepared. AhR protein levels were tested by western immunoblotting. Histone 3 was immunoblotted as an internal control. B. The 2336/2315 fragment of the mouse aB-crystallin gene containing the XRE-like motif was synthesized and labeled with 32 P. Nuclear extracts were prepared from aTN4 cells transfected with pcDNA3.1/B6AhR and pcDNA/ARNT, treated with 10 nM TCDD or DMSO (0.01%) for 2 h. Gel shift was performed as described under '' Materials and Methods''. Arrows indicate the specific protein-DNA band. The band was induced by AhR/ARNT and increased by the combination of AhR/ARNT and 10 nM TCDD. The band was competed by 25-fold excess unlabeled probe or AhR antibody, but not by ARNT antibody. C. Gel shifts testing the binding of AhR to the XRE-like motif or to its mutant sequences. Equal amounts of nuclear extract from aTN4 cells transfected with pcDNA3.1/B6AhR and pcDNA/ARNT, treated with TCDD were incubated with a and all efforts were made to minimize suffering. After removing fascia, fat, and connective tissue, the muscles were washed three times in PBS, minced into small pieces and digested with 0.2% trypsin-EDTA (Invitrogen) at 37uC for 30 min before centrifugation at 2,000 rpm for 5 min. The pellets were resuspended in DMEM and incubated at 37uC and 5% CO 2 for 30 min. Non-adherent cells were removed and the adherent cells were washed with PBS to discard remaining myogenic cells. The fibroblasts were cultured in DMEM medium with 10% fetal bovine serum for several generations.
Protein and mRNA Preparation
Mice were euthanized by CO 2 and the cornea, lens, retina, heart, and limb skeletal muscles were surgically excised. Tissue pellet were resuspended in RIPA buffer (Pierce) supplemented with protease and phosphatase inhibitor cocktail (Pierce), homogenized for 30 sec on ice and centrifuged at 14,0006g for 15 min at 4uC. Aliquots of the supernatant fractions were stored at 280uC. For protein preparation, cells were washed by PBS, scrapped and collected. Total protein was extracted at 4uC in RIPA buffer supplemented with protease and phosphatase inhibitor cocktail. The cell lysates were centrifuged and aliquots of the supernatant fractions stored at 280uC. Cell nuclear extracts were prepared using the nuclear extract kit (Active Motif) following the instructions of the manufacturer. For mRNA preparations, the specified tissues were snap frozen in liquid nitrogen and stored at 280uC. mRNA extractions were performed using a Qiagen RNeasy Plus Mini Kit (Qiagen).
Western blot
Protein lysates were quantified using a BCA Protein Assay kit (Pierce). Equal amounts of protein were subjected to 4-12% BisTris SDS-PAGE (Invitrogen) and transferred electrophoretically onto a nitrocellulose membrane. The membrane was blocked with 5% fat-free milk/PBST, sequentially incubated with primary antibody overnight at 4uC and secondary antibodies for 1 h at room temperature, and autoradiographed by the ECL detection kit (Pierce).
In Vitro Transcription and Translation 1 mg pcDNA3.1/B6AhR and 1 mg pcDNA/ARNT were separately transcribed and translated in vitro using a rabbit reticulocyte lysate expression kit (Promega) following the manufacturer's instruction. The reaction mixtures were combined and incubated with 100 nM TCDD or DMSO (0.01%) for 1 h at 30uC. 5 ml of each lysate was used for gel shift experiments.
Gel Shift 10 mg nuclear protein or 5 ml in vitro-translated protein were mixed with 1 ml poly (dI-dC) in 10 ml buffer (25 mM Hepes, 60 mM KCl, 1 mM DTT, 1% glycerol, 2% CHAPs, 4 mM spermidine) on ice for 30 min. 1 ml 32 P-labeled oligonucleotides was incubated in the reaction mixture for 30 min at room temperature. For competition experiments, a 25-to 100-fold molar excess of unlabeled oligonucleotides was incubated with the nuclear extract for 30 min on ice prior to addition of the 32 P-labeled probe. Supershift tests were conducted by incubation of 1 mg AhR or ARNT antibody with nuclear extract prior to the addition of the 32 P-labeled probe. Protein-DNA complexes were analyzed in a 6% polyacrylamide DNA retardation gel (Invitrogen) using 0.56 Tris borate EDTA (TBE) buffer. The gel was dried and subjected to autoradiography.
Chromatin Immunoprecipitation (ChIP) Assays
Cells were rinsed with PBS and crosslinked with 1% formaldehyde for 10 min at room temperature; the reaction was stopped by addition of 0.125 M glycine. Cells were rinsed and collected in ice-cold PBS and centrifuged at 3,000 rpm for 5 min at 4uC. The cell pellets were resuspended in 1 ml lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM MgCl, 1 mM EGTA, 0.5% TritonX-100, protease inhibitor cocktail freshly added) and incubated on ice for 10 min. The cell lysates were centrifuged at 5,000 rpm for 5 min and nuclei were resuspended in 300 ml nuclear lysis buffer (1% SDS, 50 mM Tris-HCl, pH 8.0, 10 mM EDTA, protease inhibitor cocktail freshly added). The suspensions were sonicated to produce DNA fragments of 300-900 bp, centrifuged at 13,000 rpm for 10 min, and the supernatant fractions removed. The supernatant fractions were pre-blocked with protein G sepharose beads in nine volumes of dilution buffer (lysis buffer) for 1 h at 4uC and centrifuged; subsequently, the supernatant fractions were incubated with 2 ug goat anti-AhR antibody overnight at 4uC with gentle rotation. The immunocomplexes were precipitated by protein G sepharose beads, pelleted and washed sequentially with buffer I (0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM Tris, pH 8, 150 mM NaCl), buffer II (0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM Tris, ph 8, 500 mM NaCl), buffer III ( 0.25 M LiCl, 1% NP-40, 1% NaDOC, 1 mM EDTA, 10 mM Tris, pH 8), and three times with TE buffer. The samples were boiled, centrifuged and the supernatant fractions collected. After dilution with three volumes of water, 2 ml sample were subjected to 50 PCR cycles or processed by real time PCR on a 7900HT Fast Real-Time PCR System (Applied Biosystem) using SYBRH Green PCR Master Mix kit (Applied Biosystem). The primers for amplifying the 2265 to 2466 fragment of the aB-crystallin enhancer containing the XRE-like motif were: 59-AGC TCA TTC CAG TCA GA and 59-GCT AGG ATG GAG CCT GGA AT.
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